Impaired Structural Connectivity in Parkinson’s Disease and its Neuropsychological Correlates
Objective: The aim of this study was to detect disrupted structural connectivity in Parkinson's disease (PD) patients classified according to their cognitive status, with and…Cognitive profile of the COPPADIS cohort: Sociodemographic characteristics, lifestyle, neuropsychiatric and non-motor(NM) associated features and potentially treatable variables
Objective: To explore the cross-sectional cognitive characteristics of the COPPADIS cohort and to identify associations between cognitive performance and lifestyle, neuropsychiatric symptoms, NM features and…Cognitive and psychiatric symptoms are associated with walking difficulties in mild Parkinson’s disease
Objective: To investigate the association of different aspects of cognitive impairment, depression and anxiety with walking difficulties in daily life in persons with mild PD.…Modeling Cerebellar Limb Dysmetria and Impaired Spatial Memory in Rats Using Lamivudine: A preliminary study
Objective: This study is aimed at determining if any constituent of combination antiretroviral therapy (cART) can induce cerebellar limb dysmetria and spatial memory impairments in…White matter abnormalities and its relation to cognitive impairment in isolated Rapid Eye Movement sleep behavior disorder
Objective: To study white matter (WM) abnormalities and global cortical atrophy in isolated rapid eye movement sleep behavior disorder (IRBD) patients and its relation to cognitive…Cholinergic basal forebrain atrophy and cognitive decline in advanced Parkinson’s disease
Objective: To examine the relationship between cognitive decline and atrophy across cholinergic basal forebrain (BF) subregions in advanced Parkinson’s disease (PD). Background: Recent studies show…Behavioral and Psychological Symptoms in Patients with Movement Disorders
Objective: To find out the prevalence of neuropsychiatric symptoms in patients with Movement Disorders. To find out the relationship between cognitive impairment and neuropsychiatric symptoms…Increased neurofilament light chain plasma levels as a biological marker of mild cognitive impairment in Parkinson’s disease
Objective: To examine whether PD-MCI patients have increased plasma neurofilament light chain (NfL) levels compared to PD with normal cognition (PD-NC) and healthy controls (HC).…The relationship between neuromelanin-sensitive MRI, [123I] meta-iodobenzylguanidine scintigraphy and cognition, in patients with Parkinson’s disease
Objective: We investigate the relationship between the contrast ratio of locus coeruleus (LC-CR) in neuromelanin-sensitive MRI(NMI), MIBG scintigraphy, and cognition/hallucination, in patients with Parkinson’s disease.…Pattern of cerebral perfusion in early de novo Parkinson’s disease with mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging
Objective: We aimed to investigate the patterns of cerebral perfusion in early de novo Parkinson’s disease (PD) patients with different cognitive states and to determine…
- « Previous Page
- 1
- …
- 60
- 61
- 62
- 63
- 64
- …
- 128
- Next Page »